Healthcare -
Biotechnology - NASDAQ - US
$ 0.7846
-7.47 %
$ 36.7 M
Market Cap
-0.88
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Reviva Pharmaceuticals Holdings, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 30.8 M |
| Operating Income | -30.8 M |
| Other Expenses | -880 K |
| Net Income | -29.9 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Feb-2020 | Feb-2019 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0.7 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | (0.7) | 0 | 0 |
| OPERATING INCOME | |||||||
| Operating Expenses | 30.8 | 39.5 | 24.3 | 10.1 | 2.4 | 0.4 | 1.1 |
| Selling, General and Administrative Expenses | 7.9 | 8.1 | 5.4 | 5.3 | 2.1 | 0.2 | 0.2 |
| Research and Development Expenses | 22.9 | 31.4 | 18.9 | 4.9 | 0.3 | 0.2 | 0.9 |
| Operating Income | (30.8) | (39.5) | (24.3) | (10.1) | (2.4) | (0.4) | (1.1) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 18.5 K | 0 | 0.2 | 2.41 K | 1.5 | 0.5 | 0 |
| Total Other Income | 0.9 | 39.5 | 11.9 K | 1.6 | (1.3) | (0.5) | (0.6) |
| Pre-Tax Income | (29.9) | (39.2) | (24.3) | (8.5) | (3.8) | (0.8) | (1.7) |
| NET INCOME | |||||||
| Tax Provision | 19.5 K | 16.9 K | 20.8 K | 6 K | 800 | 800 | 800 |
| Net Income | (29.9) | (39.3) | (24.3) | (8.5) | (3.8) | (0.8) | (1.7) |
| EPS | 0.9 | 1.65 | 1.45 | 0.576 | 1.24 | 0.31 | 0.281 |